Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). (Q42659869)
Jump to navigation
Jump to search
scientific article published on August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). |
scientific article published on August 2001 |
Statements
Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD) (English)
Vieta E
1 reference
E Vieta
M Herraiz
A Fernández
C Gastó
A Benabarre
F Colom
A Martínez-Arán